Abstract
Connective tissue diseases predominating in females include disseminated lupus erythematosus, antiphospholipid syndrome, primary pulmonary hypertension, Sjögren's syndrome, and rheumatoid arthritis. Pulmonary involvement is not uncommon and clinical expression may be modified by pregnancy. In addition, a certain number of drugs used for their treatment have an effect on fertility and pregnancy. We review here these different aspects and female-specific diagnostic and therapeutic features of connective tissue diseases.
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antiphospholipid Syndrome / complications*
-
Antiphospholipid Syndrome / diagnosis
-
Antiphospholipid Syndrome / drug therapy
-
Antiphospholipid Syndrome / epidemiology
-
Arthritis, Rheumatoid / complications*
-
Arthritis, Rheumatoid / diagnosis
-
Arthritis, Rheumatoid / drug therapy
-
Arthritis, Rheumatoid / epidemiology
-
Female
-
Humans
-
Hypertension, Pulmonary / complications*
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / drug therapy
-
Hypertension, Pulmonary / epidemiology
-
Lung Diseases / etiology*
-
Lupus Erythematosus, Systemic / complications*
-
Lupus Erythematosus, Systemic / diagnosis
-
Lupus Erythematosus, Systemic / drug therapy
-
Lupus Erythematosus, Systemic / epidemiology
-
Pregnancy
-
Sex Distribution
-
Sex Factors
-
Sjogren's Syndrome / complications*
-
Sjogren's Syndrome / diagnosis
-
Sjogren's Syndrome / drug therapy
-
Sjogren's Syndrome / epidemiology
-
Steroids
-
Women's Health*
Substances
-
Anti-Inflammatory Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Steroids